REFERENCES
- Whitcher J, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79:214–221
- Shah A, Sachdev A, Coggon D, et al. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br J Ophthalmol 2011; 95:762–767
- Mather R, Karenchak LM, Romanowski EG, et al. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463–466
- Chaudhary N, Flynn HW, Murray TG, et al. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 1999;128:509–510
- Kunimoto D, Sharma S, Garg P, et al. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: emerging resistance. Ophthalmology 1999;106:80–85
- Moshirfar M, Mirzaian G, Feiz V, et al. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refractive Surg 2006;32:515–518
- Srinivasan M, Mascarenhas J, Rajaraman R, et al. The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol 2012;130:143–150
- Wilhelmus K, Liesegang TJ, Osato MS, et al. Laboratory diagnosis of ocular infection. In: Specter S, ed. Cumitech: cumulative techniques and procedures in clinical microbiology. American Society for Microbiology Press, 1994
- Andrews J, for the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 8). J Antimicrobial Therapy 2009;64:454–489
- Hsu H, Nacke R, Song J, et al. Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states. Eye Contact Lens 2010;36:195–200
- Drlica K, Zhao X. Mutant selection window hypothesis updated. Clin Infectious Dis 2007;44:681–688
- Epstein S, Bottone D, Asbell P. Susceptibility testing of clinical isolates of Pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating Pseudomonas ocular infections. Eye Contact Lens 2006;32:240–244
- Fintelmann R, Hoskins ES, Lietman TM, et al. Topical fluoroquinolone use as a risk factor for in vitro resistance in ocular cultures. Arch Ophthalmol 2011;129:399–402
- Milder E, Vander J, Shah C, et al. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 2012;119:1420–1424
- Lalitha P, Srinivasan M, Manikandan P, et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infectious Dis 2012;54:1381–1387